Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -33044.00% is 3715% below its 5-year average of -866.27%, near the low end of its 5-year range (-33044.00%–23.63%).
1890.24% below its 12-month average of -1660.30%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-33044.00%
NET PROFIT MARGIN AVG TTM
-1660.30%
NET PROFIT MARGIN AVG 3Y
-1244.01%
NET PROFIT MARGIN AVG 5Y
-866.27%
NET PROFIT MARGIN AVG 10Y
-2288.63%
NET PROFIT MARGIN AVG 15Y
-1198.44%
NET PROFIT MARGIN AVG 20Y
-694.95%
CURRENT VS TTM AVG
-1890.24%
CURRENT VS 3Y AVG
-2556.26%
CURRENT VS 5Y AVG
-3714.53%
CURRENT VS 10Y AVG
-1343.83%
CURRENT VS 15Y AVG
-2657.26%
CURRENT VS 20Y AVG
-4654.90%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 657 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
iBio, Inc.
Market Cap
$71.38M
Net Profit Margin
-33044.00%
TTM Avg
-1660.30%
3Y Avg
-1244.01%
5Y Avg
-866.27%
Market Cap
$70.95M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
Market Cap
$74.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13227.36%
5Y Avg
-12286.00%
Market Cap
$68.42M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$68.08M
Net Profit Margin
-1.87%
TTM Avg
3.14%
3Y Avg
-4.53%
5Y Avg
-2.69%
Market Cap
$76.11M
Net Profit Margin
-210.75%
TTM Avg
-289.10%
3Y Avg
-513.23%
5Y Avg
-2388.54%
Market Cap
$65.93M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$77.44M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $71.38M | -33044.00% | -1660.30% | -1244.01% | -866.27% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.95M | -105.29% | -106.48% | -112.00% | -95.88% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.00M | 0.00% | 0.00% | -13227.36% | -12286.00% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.42M | 163.32% | -34.49% | -63.76% | -75.19% |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | -1.87% | 3.14% | -4.53% | -2.69% |
| Hyperfine, Inc. (HYPR)vs › | $76.11M | -210.75% | -289.10% | -513.23% | -2388.54% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.93M | -235.00% | -200.38% | -100.19% | -66.80% |
| Cingulate Inc. (CING)vs › | $65.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outset Medical, Inc. (OM)vs › | $77.44M | -63.06% | -90.45% | -113.67% | -137.76% |
| Heron Therapeutics, Inc. (HRTX)vs › | $65.19M | -22.52% | -11.22% | -69.63% | -131.75% |
Operating Margin
-35141.0%
Net Profit Margin
-33044.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | -5720.00% |
| 2025-06-30 | -2581.50% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -2182.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -4444.57% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -11492.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -27957.38% |
| 2022-03-31 | -688.33% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | -10641.67% |
| 2021-06-30 | 23.63% |
| 2021-03-31 | -1001.44% |
| 2020-12-31 | -1153.05% |
| 2020-09-30 | -1837.32% |
| 2020-06-30 | -315.89% |
| 2020-03-31 | -4870.83% |
| 2019-12-31 | -1198.09% |
| 2019-09-30 | -4132.41% |
| 2019-06-30 | -566.42% |
| 2019-03-31 | -801.33% |
| 2018-12-31 | -686.48% |
| 2018-09-30 | -9773.33% |
| 2018-06-30 | -4854.95% |
| 2018-03-31 | -5079.49% |
| 2017-12-31 | -2548.37% |
| 2017-09-30 | -3136.07% |
| 2017-06-30 | -2944.90% |
| 2017-03-31 | -10575.68% |
| 2016-12-31 | -4305.33% |
| 2016-09-30 | -2267.41% |
| 2016-06-30 | -973.45% |
| 2016-03-31 | -801.06% |
| 2015-12-31 | -1676.12% |
| 2015-09-30 | -1128.13% |
| 2015-06-30 | -596.52% |
| 2015-03-31 | -480.52% |
| 2014-12-31 | -450.41% |
| 2014-09-30 | -172.16% |
| 2014-06-30 | -557.07% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | -213.52% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | -525.65% |
| 2012-06-30 | -387.87% |
| 2012-03-31 | -833.61% |
| 2011-12-31 | -683.40% |
| 2011-09-30 | 119.60% |
| 2011-06-30 | -460.06% |
| 2011-03-31 | -1722.21% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | -140.62% |
| 2009-06-30 | -346.32% |
| 2009-03-31 | -99.12% |
| 2008-12-31 | -148.76% |
| 2008-09-30 | -162.85% |
| 2008-06-30 | -675.94% |
| 2008-03-31 | -122.45% |
| 2007-12-31 | -147.36% |
| 2007-09-30 | -158.18% |
